373-45-5

Basic information

• Product Name: 2-[2-(2-Fluoroethoxy)ethoxy]ethanol
• Synonyms: 2-[2-(2-Fluoroethoxy)ethoxy]ethanol
• CAS NO: 373-45-5
• Molecular Formula: C₆H₁₃FO₃
• Molecular Weight: 152.164
• Mol File: 373-45-5.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 221.6°Cat760mmHg
• Flash Point: 110°C
• Appearance: /
• Density: 1.062g/cm³
• Vapor Pressure: 0.022mmHg at 25°C
• Refractive Index: 1.404
• CAS DataBase Reference: 2-[2-(2-Fluoroethoxy)ethoxy]ethanol(CAS DataBase Reference)
• NIST Chemistry Reference: 2-[2-(2-Fluoroethoxy)ethoxy]ethanol(373-45-5)
• EPA Substance Registry System: 2-[2-(2-Fluoroethoxy)ethoxy]ethanol(373-45-5)

Safety Data

• Hazardous Substances Data: 373-45-5(Hazardous Substances Data)

Usage

General Description

2-[2-(2-Fluoroethoxy)ethoxy]ethanol, also known as fluorosolv, is a chemical compound with the molecular formula C6H14F2O3. It is a colorless, clear liquid with a faint odor and is used primarily as a solvent in various industrial applications. 2-[2-(2-Fluoroethoxy)ethoxy]ethanol is commonly used in the electronics industry as a solvent for cleaning and degreasing electronic components. It is also used in the production of other chemicals and as a solvent in the manufacturing of adhesives and coatings. Additionally, it is used as a chemical intermediate in the production of pharmaceuticals and agrochemicals. 2-[2-(2-Fluoroethoxy)ethoxy]ethanol is considered to have low toxicity and is not expected to pose significant risks to human health or the environment when used according to proper handling and storage procedures.

InChI:InChI=1/C6H13FO3/c7-1-3-9-5-6-10-4-2-8/h8H,1-6H2

Upstream product

• 19249-03-7 triethylene glycol di-(p-toluenesulfonate) 
• 75-21-8 oxirane 
• 371-62-0 2-fluoroethanol 

Downstream Products

• 1181376-60-2 1-chloro-4-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)-2-nitrobenzene 
• 1071467-74-7 4-(2-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)quinolin-6-yl)benzenamine 
• 1071467-71-4 4-(2-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)quinolin-6-yl)-N,N-dimethylbenzenamine 
• 1071467-76-9 4-(2-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)quinolin-6-yl)-N-methylbenzenamine 
• 1067907-19-0 C₁₂H₁₅BrFIO₃ 
• 937183-75-0 tert-butyl (E)-4-(2-(6-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)-5-iodopyridin-3-yl)vinyl)phenyl(methyl)carbamate 
• 937183-73-8 (E)-(5-bromo-6-{2-[2-(2-fluoroethoxy)ethoxy]ethoxy}pyridin-3-yl)-2-(4-hydroxyphenyl)-ethylene 
• 937183-69-2 (E)-4-(2-(5-bromo-6-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)phenyl acetate 
• 937183-68-1 tert-butyl (E)-4-(2-(5-bromo-6-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)pyridin-3-yl)vinyl)phenyl(methyl)carbamate 
• 937183-67-0 (E)-(5-bromo-6-{2-[2-(2-fluoroethoxy)ethoxy]ethoxy}pyridin-3-yl)-2-(4-methylaminophenyl)-ethylene 
• 937183-66-9 (E)-(5-bromo-6-{2-[2-(2-fluoroethoxy)ethoxy]ethoxy}pyridin-3-yl)-2-(4-dimethylaminophenyl)-ethylene 

Relevant articles and documents

NOVEL IMAGING AGENTS FOR DETECTING NEUROLOGICAL DYSFUNCTION

Disclosed here in are compounds and methods of diagnosing Alzheimer's Disease or a predisposition thereto in a mammal, the method comprising administering to the mammal a diagnostically effective amount of a radiolabeled compound, wherein the compound is selected from the group consisting of radiolabeled flavones, coumarins, carbazoles, quinolinones, chromenones, imidazoles and triazoles derivatives, allowing the compound to distribute into the brain tissue, and imaging the brain tissue, wherein an increase in binding of the compound to the brain tissue compared to a normal control level of binding indicates that the mammal is suffering from or is at risk of developing Alzheimer's Disease